XPEV - XPeng Posts Strong Results Joins Larimar Therapeutics Transcat And Other Big Stocks Moving Higher On Tuesday | Benzinga
U.S. stocks were mostly higher, with the Dow Jones index gaining around 50 points on Tuesday.
Shares of XPeng Inc. (NYSE:XPEV) rose sharply during Tuesday's session after the company reported better-than-expected first-quarter results and issued second-quarter guidance.
XPeng reported fiscal first-quarter sales growth of 62.3% year-on-year, to 6.55 billion Chinese Yuan ($0.91 billion), beating the analyst consensus estimate of 6.17 billion Chinese Yuan ($0.87 billion). Total revenues declined 49.8% sequentially. Adjusted net loss per ADS of $0.21 beat the analyst consensus loss estimate of $0.27, according to data from